SEC Form 4 · accession 0001209191-19-000587
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elan Ezickson
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 2, 2019 · 9:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2018 | A | 80,214 | $0.00 | A | 80,214 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F180,214 shares vest on 12/31/2019.